Cargando…
TREM-1, TREM-2 and their association with disease severity in patients with COVID-19
BACKGROUND: Delayed diagnosis and inadequate treatment caused by limited biomarkers are associated with the outcomes of COVID-19 patients. It is necessary to identify other promising biomarkers and candidate targets for defining dysregulated inflammatory states. METHODS: The triggering receptors exp...
Autores principales: | Fan, Ruyue, Cheng, Zuowang, Huang, Zhisheng, Yang, Ying, Sun, Na, Hu, Bin, Hou, Peibin, Liu, Bo, Huang, Chuanjun, Liu, Shuai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583614/ https://www.ncbi.nlm.nih.gov/pubmed/37848000 http://dx.doi.org/10.1080/07853890.2023.2269558 |
Ejemplares similares
-
Function of TREM1 and TREM2 in Liver-Related Diseases
por: Sun, Huifang, et al.
Publicado: (2020) -
The biology of TREM receptors
por: Colonna, Marco
Publicado: (2023) -
TMEM59 interacts with TREM2 and modulates TREM2-dependent microglial activities
por: Liu, Zhaoji, et al.
Publicado: (2020) -
sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021) -
Association of rs2062323 in the TREM1 gene with Alzheimer's disease and cerebrospinal fluid‐soluble TREM2
por: Wang, Zuo‐Teng, et al.
Publicado: (2023)